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Background: Malaria can be caused by five Plasmodium species. Due to their higher prevalence, much of the
research concentrates on Plasmodium falciparum and Plasmodium vivax. In Burkina Faso, where P. falciparum
co-exists with Plasmodium malariae and Plasmodium ovale, there is not much data about the prevalence of the
latter two species across human population. Moreover, interactions between co-infecting Plasmodium species are
not documented. The aim of the current research is to determine species-specific prevalence and temporal
distribution. The potential interactions between co-infecting Plasmodium species amongst the child-aged
population in Burkina Faso are also discussed.
Methods: The study took place in the Sudanese savannah zone in Burkina Faso in a rural village, Laye. Surveys
were conducted during the wet season across four years, 2007 to 2010. Volunteers aged three to 15 years with
parental signed consent were enrolled. Ten children per week were screened for any history of pain, fever.
Parasitological data were obtained by blood slide processing.
Results: Three sympatric Plasmodium species were recorded during this study with an average prevalence of 70.7%.
Species temporal distribution showed an increase of P. malariae parasite prevalence from 0.9% in 2007 to 13.2% in
2010. Within a season, P. falciparum occurred in the overall study period while P. malariae and P. ovale were highly
prevalent after the rainy part of this period. Species-specific infection analysis showed that in a comparison of
mono-infections, P. malariae gametocyte prevalence and median density were higher than those of P. falciparum
(88.9% vs 34.5% and 124.0 vs 40.0 gametocytes/μl, respectively). Likewise, in P. falciparum co-infections with
P. malariae or P. ovale, gametocyte prevalence was also higher than in P. falciparum mono-infection. However,
in P. falciparum mixed infection with P. malariae, P. falciparum gametocyte prevalence and median density as well
as asexual form density decreased compared to P. falciparum mono-infection while for P. malariae mono-infection,
only asexual form density significantly vary.
Conclusion: These data revealed high gametocyte prevalence in other Plasmodium species than P. falciparum with
a significant variation of P. malariae gametocyte carriers and gametocyte density across years. Molecular tools and
entomological studies are needed to highly assess species-specific contribution to malaria transmission.
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Malaria remains a huge burden for human populations
living in tropical areas. More than two million malaria
cases were recorded in 2010, with the heaviest mortality
rates in children living in sub-Saharan Africa [1]. During
the past decade, the scale-up of malaria control inter-
ventions has resulted in considerable reductions in mor-
bidity and mortality associated with malaria in parts of
Africa [2,3]. Despite these efforts, malaria continues to
pose a major public health threat in many African coun-
tries [1] and recent work suggests that control efforts
can be followed by infections rebounding to pre-
intervention levels [4]. Successful local strategies for
malaria control could be based on malaria surveys,
which are an important tool to investigate the impact of
the disease on population health status in endemic areas
[5]. A primary component for this kind of survey should
be the determination of parasite species diversity be-
cause optimal control measures are different for the
different species of malaria.
Currently, malaria can be caused by five Plasmodium
species which include Plasmodium falciparum, Plasmo-
dium malariae, Plasmodium ovale, Plasmodium vivax
and, more recently, Plasmodium knowlesi [6]. Plasmo-
dium falciparum is the most prevalent in Africa and the
most pathogenic of these, but in most malaria endemic
regions multiple sympatric species are found and co-
infection within individual human hosts or the mosquito
vector population is common. In Africa, P. malariae is
the species most frequently found in sympatry with
P. falciparum [7]. Plasmodium inter-species interactions
have been the focus of interest of number of studies
[8-11]. The co-infecting species interactions in humans
can modify within-host dynamics [12,13] and alter trans-
mission potential [8]. The effect of mixed species
infections on clinical outcome has been described as
both beneficial [14] and adverse [15]. Indeed, in areas
where P. falciparum co-occurred with P. malariae, field
studies reveal that this co-occurrence can reduce disease
severity [16,17], give a lower peak of parasitaemia [18]
or boost P. falciparum gametocyte production [8,9].
In Burkina Faso particularly, where P. falciparum co-
exists with P. malariae and P. ovale, there is not much
data about the interaction of co-infecting species. In fact,
only a few studies even report the prevalence of the last
two species across human population [5,19-21]. Most of
these studies were done in the past decade before the
scale up of interventions such as the availability of
artemisinin combination therapy (ACT) or the mass dis-
tribution of insecticide-treated bed nets (ITNs). In
addition, the country profile reveals an increase in ma-
laria cases from 2008 to 2010 without any information
on P. malariae and P. ovale [1], while some research
highlighted a substantial P. ovale malaria burden insub-Saharan Africa [22,23]. Moreover, in Burkina Faso,
where the carriage of P. falciparum gametocyte is im-
portant with a substantial submicroscopic part [24], the
role of P. malariae or P. ovale to this gametocytaemia
should be assessed. The aim of the current study was to
determine Plasmodium species-specific parasite and
gametocyte prevalence, their temporal distribution and
potential interaction across a child-aged population from
a rural village in Burkina Faso.Methods
Study area and period
The study took place in Laye, a small rural village
located 30 km north of Ouagadougou, Burkina Faso
(12°31’N, 1°460W). This village is situated in a Sudanese
savannah zone with one rainy season from June to
October with some fluctuation across years. In the vil-
lage, health care facilities are available and it is also a
part of the demographic surveillance system (DSS) used
by the malaria research centre of Burkina Faso for epi-
demiological studies. Residents live by subsistence farm-
ing in this Sudanese savannah area with seasonal holo-
endemic malaria. Malaria prevalence is highest in the
rainy season from June to October and peaks around
September. Plasmodium falciparum is responsible for
the major proportion of malaria infections [20]. Malaria
vectors are Anopheles gambiae complex members and
Anopheles funestus groups with other minor vectors
[25]. The present survey was conducted in the wet sea-
son for four consecutive years from 2007 to 2010. The
study was coupled with mosquito larvae sampling with
data collection beginning when breeding sites were pro-
ductive. Thus, the exact time of samples collection was
determined by the beginning of the rains and varied
across the four sampling years.Study population
The study population included children aged three to
15 years. Based on the most recent update of the DSS
database, a list of potential children to be enrolled was
done each year. Once a week, the households of a
computer-generated sample of 10 children were visited
by a field worker and a member of the research staff to
obtain informed consent for the participation of these
children in the study. Only volunteer children with
signed consent were brought to the CNRFP (Centre Na-
tional de Recherche et de Formation sur le Paludisme),
the national malaria research centre, and enrolled for
parasite detection. In situ, they were asked for any his-
tory of pain and examined by a physician. Axillary tem-
perature was taken and a blood sample by finger prick
was collected.
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The blood slide processing was made from finger-prick
blood of each individual. The slides were left to air dry
and stained with 5% Giemsa for 35 min. One hundred
high-power fields (HPF) were examined, and the number
of malaria parasites of each species and stage was
recorded. The number of parasites per ml of blood was
calculated, assuming 200 white blood cells per high-
power field and a fixed white cell count of 8,000/μl. Each
blood slide sample was read independently by two
microscopists. The mean of the results of both mic-
roscopists was taken as the parasite density. In the event
of a discrepancy between the two readers, in terms of
species, presence or absence of malaria parasites, or if
parasite densities differed by more than 30%, a third
reader was involved. In this case, the arithmetic mean of
the two closest readings was used as the final value for
parasite density. A slide was considered negative if no
parasite stage were seen after the examination of 100
fields.Ethical consideration
The study protocol was reviewed and approved by the eth-
ics committee for biomedical research of the Ministry of
Health of Burkina Faso (code N° 2006–032). The study
procedures, benefits and risks were explained to the
children’s parents or legal guardians and their signed
consent was obtained. After each assay, symptomatic
subjects were treated with the combination of artemether-
lumefantrine (CoartemW) according to relevant regulations
of Burkina Faso’s Health Ministry. Asymptomatic subjects
were followed up by the field worker in the week.Meteorological data
The daily rainfall data come from the DGMAC, (Direc-
tion Générale de la Météorologie et de l’Aviation Civile),
the country meteorological data collection and reporting
system. The monthly mean rainfall was use for analysis.Table 1 Study population characteristics
Percentage of children per seasons
2007 2008 2009 2010
(n = 212) (n = 274) (n = 177) (n = 167)
Age in years
mean (SD*) 9.5 (3.4) 7.6(1.8) 7.7(1.3) 7.6 (1.1)
Median (IQR*) 9.6 (7.1-12.0) 7.4 (6.0-9.3) 7.4 (6.6-8.7) 7.7 (6.7-8.4)
Genders,%
Female 46.7 47.4 48.0 46.1
Male 53.3 52.6 52.0 53.9
Fever 21.2 20.1 22.0 10.2
*SD = Standard deviation, IQR = Interquartile Range.Data analysis
Comparison of prevalence was done using the Pearson’s
Chi square test or Fisher’s exact test with contingency
tables. For parasite density, the non-parametric Wil-
coxon rank test for two samples or Kruskal-Wallis test
for more than two samples was used. Spearman test of
correlation was used to assess the link between rainfall
and Plasmodium density. The potential interaction was
assessed by comparing species-specific mono-infection
to mixed infection. Statistical analyses were performed
in R 2.10.1 using the R Commander Package [26].
P-value of 0.05 or lower was considered statistically
significant.Results
Study population characterization
Some 830 children (212, 274, 177 and 167 from trans-
mission seasons 2007, 2008, 2009 and 2010, respectively)
participated in the study. The mean age in the study
group was 8.1 ± 1.7 years. Children of both genders took
equal part in this study: 52.9% (males) vs 47.1%
(females). Across years, gender distribution (Table 1) did
not vary significantly (χ2 = 0.15, df = 3, p-value = 0.98).
On average, across years, 18.8% of the study population
presented with fever and 76.3% of these fever cases were
coupled with Plasmodium infection.Plasmodium species occurrence and temporal distribution
In the study period, three parasite species: P. falciparum,
P. malariae and P. ovale were identified. Across years,
the average Plasmodium infection prevalence was 70.7%.
Plasmodium falciparum was the predominant species
with a prevalence of 68.19% followed by P. malariae
(6.51%) and P. ovale (1.08%). Several mixed infections
were reported with co-infection of P. falciparum and
P. malariae (4.34%) and co-infection of P. falciparum
with P. ovale (0.72%). No co-infections of P. malariae
with P. ovale were observed, though with their low over-
all infection prevalence this is not surprising.
In addition, from 2007 to 2010, Plasmodium infection
prevalence showed slight variation with gametocyte
prevalence being significantly different across the four
seasons (χ2 = 12.8, df = 3, p-value = 0.005). Plasmodium
malariae infection prevalence was also variable across
years (Fisher’s Exact Test, p-value = 3.93e-06) with an in-
crease from 0.9% in 2007 to 13.2% in 2010 (Table 2). As
with P. malariae overall parasite infection prevalence,
gametocyte prevalence also showed a variation across
years with higher gametocyte prevalence (14.1%) in
2010. However, P. falciparum and P. ovale infection
prevalence do not significantly vary between the trans-
mission seasons.
Table 2 Plasmodium species prevalence across years in
the overall population
Seasons





212 274 177 167
All Plasmodium 64.2 71.9 71.2 76.6 0.06
P. falciparum 63.2 70.4 66.7 72. 5 0.2
P. malariae 0.9 5.1 8.5 13.2 3.93 e-06






136 197 126 128
All Plasmodium 33.8 36.0 38.1 53.1 0.005
P. falciparum 30.9 31.5 26.2 40.6 0.09
P. malariae 2.2 3.6 11.1 14.1 9.5 e-05
P. ovale 0.7 1.0 1.6 1.6 0.8
* p-value tests for variation across years.
A
B
Figure 1 Plasmodium species temporal variation across the study per
data were obtained from the country’s meteorological data collection and
prevalence and density in August-October during the rainy season while P
of the rainy season.
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P. falciparum being present throughout the study period
while P. malariae and P. ovale often occurred following
the rainy part of the study period (Figure 1A). In
addition, P. falciparum reached its maximum density
during the rainy part of the study period, while
P. malariae and P. ovale often peaked nearer the end of
this rainy period (Figure 1B). Moreover, Spearman test
of correlation, reported a significant positive link be-
tween P. falciparum density and rainfall (rho = 0.727,
p-value = 0.0004). However, P. malariae and P. ovale
density were not significantly correlated with rainfall
(respectively rho = −0.153, p-value = 0.53 and rho =
0.013, p-value = 0.96).
Species characteristics among the infected population
Species-specific mono-infection and mixed infection
characteristics are given in Table 3. The median age as
well as gametocyte prevalence and median density show
significant variation across species infected children (see
Table 3). Comparisons of mono-infections characteristics
show significant difference for gametocytes prevalence
and density (Fisher's Exact Test, p-value = 1.5e-06 and
Kruscal-Wallis test, HW = 15.62, df = 2, p-value =0.0004iod: parasites prevalence (A) and mean density (B). The rainfall
reporting system. Plasmodium falciparum reached its maximum
lasmodium malariae and Plasmodium ovale peaked nearer the end
Table 3 Baseline characteristics of Plasmodium species infected children*
Age, years,
median (IQR)






PF 8.0 54.6 21.2 34.5 40.0 1007.5
(6.5-9.4) (286/524) (111/524) (181/524) (19–78) (327–3826)
PM 7.6 50.0 5.6 88.9 124.0 874.0
(7.2-8.2) (9/18) (1/18) (16/18) (63–390) (603–1148)
PO 10.0 0.0 33.3 66.7 124.5 277.0
(9.6-12.2) (0/3) (1/3) (2/3) (122–127) (219–756)
PF + PM 7.2 52.8 13.9 80.6 90.0 1337.5
(6.3-8.2) (19/36) (5/36) (29/36) (38–170) (718–2031)
PF + PO 8.0 50.0 16.7 83.3 20.0 6257.5
(7.4-8.8) (3/6) (1/6) (5/6) (19–95) (2692–7476)
p-value 0.04 0.5 0.3 1.7e-12 0.0001 0.09
*PF = P. falciparum mono-infection; PM = P. malariae mono-infection; PF + PM = P. falciparum and P. malariae co-infection; PO = P. ovale mono-infection;
PF + PO = P. falciparum and P. ovale co-infection; IQR = interquartile range.
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cyte prevalence was higher in P. malariae infections
than in P. falciparum infections (88.9% vs. 34.5% re-
spectively, χ2 = 22.2, df = 1, p-value = 2.4e-06). The
median gametocyte density shows the same trend with
higher values being observed in P. malariae infections
than in P. falciparum infections (124.0 vs. 40.0 game-
tocytes/μl, Wilcoxon rank test, W = 668, p-value =
0.0003). No significant difference was found between
P. ovale gametocytes carriage or median gametocyte
density and either of the other Plasmodium species.
For age variation, the median age was significantly
higher for P. ovale mono-infections (10.0 years, IQR,
9.6-12.2) than for P. malariae (7.6 years; Wilcoxon rank
test, W = 3, p-value = 0.02) or P. falciparum (8.0 years;
W = 214, p-value = 0.03). Variables such as gender,
prevalence of fever, and asexual form median density,
did not show significant difference across mono-
infections.
Interestingly, significant differences were observed
between parasite species mono-infections and their
mixed infections for variables such as gametocytes
prevalence or density, asexual forms density, and infected
children median age. By comparing P. falciparum mono-
infections to its mixed infections, the study report that
gametocyte prevalence and median gametocyte density
were lower in mono-infections than co-infections with
P. malariae (34.5 vs 80.6; χ2 = 30.4, p = 3.5e-08 and 40.0 vs
90.0; W = 1,690, p-value = 0.002 respectively). However,
the median age of infected-children was higher in
P. falciparum mono-infections than in co-infections with
P. malariae (7.2 vs 8.0; W = 11,430.5, p-value = 0.03).
When looking at P. falciparum mixed infection with
P. ovale, gametocyte prevalence and asexual form density
were higher in mixed infections than in P. falciparum
mono-infections (83.3 vs 34.5; Fisher exact test, p-value =0.02 and 6,257.5 vs 1,007.5; W= 691, p-value = 0.02). Other
variables did not shown significant variation.
For P. malariae and P. ovale mono-infections and
their mixed infections with P. falciparum, no significant
difference was found between P. malariae mono (n = 18)
and mixed infections (n = 36), while P. ovale had a
higher median density of asexual forms in mixed
infections compared to mono-infections (6,257.5 vs
277.0; W = 18, p-value = 0.02). Table 4 summarizes the
species-specific infection pair comparisons.
Species characteristic among Plasmodium specific-
infected children
To assess species interaction, species-specific charac-
teristics in mono- and mixed infections were compared.
Plasmodium falciparum gametocyte prevalence, gameto-
cyte median density as well as the median asexual form
density in mono-infections was higher than those in
mixed infections with P. malariae (χ2 = 4.8, df = 1,
p-value = 0.03, W = 879.5, p-value = 0.009 and W =
10,849.5, p-value = 0.03 respectively) (see Table 5). In its
co-infection with P. ovale, no significant difference was
observed for either gametocyte prevalence (33.3% vs
34.5%) or gametocyte density (23.5 vs 40.0 gametocytes/
μl) in comparison with mono-infection (Fisher exact
test, p = 1.0 and Wilcoxon rank test, p = 0.2 respectively).
However, P. falciparum asexual form median density
was higher in its co-infection with P. ovale (5,563.5
parasites/μl) compared to mono-infection (1,007.5 para-
sites/μl) (W = 758, p-value = 0.04).
Among P. malariae-infected children, only asexual
forms median density shows a significant difference
(W = 163, p-value = 0.003) between mono-infections and
mixed infections (Table 5). Plasmodium ovale does
not show any significant variation between mono- and
mixed infections.













PF vs PM vs PO 0.08 0.2 0.2 1.5e-06 0.0004 0.4
PF vs PM 0.8 0.7 0.1 2.436e-06 0.0003 0.5
PF vs PO 0.04 0.09 0.5 0.3 0.07 0.2
PM vs PO 0.02 0.2 0.3 0.4 1.0 0.2
PF vs PF + PM 0.03 0.8 0.3 3.5e-08 0.002 0.5
PF vs PF + PO 0.7 0.8 1.0 0.02 0.7 0.02
PM vs PF + PM 0.1 0.8 0.6 0.7 0.3 0.1
PO vs PF + PO 0.05 0.1 1.0 1.0 0.4 0.002
*PF = P. falciparum mono-infection; PM = P. malariae mono-infection; PF + PM = P. falciparum and P. malariae co-infection; PO = P. ovale mono-infection;
PF + PO = P. falciparum and P. ovale co-infection; IQR = interquartile range.
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Three sympatric species, P. falciparum, P. malariae and
P. ovale were observed in the study site, with P. falcip-
arum being the most prevalent species. Plasmodium
falciparum infection is widely prevalent across the entire
study period with some monthly fluctuation while
P. malariae and P. ovale individually peak at the end of
the rainy part of the study period. Similar fluctuation
between P. malariae and P. falciparum densities has
been reported by several other studies [19,27]. Offset
peaks may be explained by competition between both
species and the fact that immune-protection induced by
infection with P. falciparum does not seem to be effect-
ive against P. malariae [19]. It has also been suggested
that P. malariae can be found at higher prevalence when




Plasmodium falciparum infection characteristics
PF 34.5 (181/524)
PF + PM 16.7 (6/36)
PF + PO 33.3 (2/6)
PF vs PF + PM, p-value 0.03
PF vs PF + PO, p-value 1.0
Plasmodium malariae infection characteristics
PM 88.9 (16/18)
PF + PM 72.2 (26/36)
PM vs PF + PM, p-value 0.3
Plasmodium ovale infection characteristics
PO 66.7 (2/3)
PF + PO 83.3 (5/6)
PO vs PF + PO, p-value 1.0
*PF = P. falciparum mono-infection; PM = P. malariae mono-infection; PF + PM = P. fa
PF + PO = P. falciparum and P. ovale co-infection; IQR = interquartile range.is alleviated from the suppressive effect of P. falciparum
[10,18]. A similar phenomenon may explain P. ovale
occurrence. This finding revealed a kind of alternation
in the relative contribution of each species to the total
parasite indexes that occurred in the study area [28].
The significant increase of P. malariae prevalence
throughout the four-year study period allows speculation
on positive selection of this parasite by medication. In
fact, in the study site and its surrounding villages many
research activities occurred with treatment of symp-
tomatic children [24,29,30] or a trial for intermittent
preventive treatment of malaria in children (IPTc)
[31,32]. These symptomatic cases are rarely P. malariae
infected-children because of this species low density.
As a result, P. malariae remains in circulation despite





Median (IQR) Median (IQR)
40.0 (19–78) 1007.5 (327–3826)
16.0 (10–22) 645.0 (200–1277)
23.5 (16–31) 5563.5 (2510–7163)
0.01 0.03
0.2 0.04
124.0 (63–390) 874.0 (603–1148)
99.0 (49–173) 377.5 (132–751)
0.5 0.003
124.5 (122–127) 277.0 (219–756)
20.0 (19–56) 341.0 (183–733)
0.4 0.9
lciparum and P. malariae co-infection; PO = P. ovale mono-infection;
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to drug, P. malariae prevalence and density goes up
because of the suppressive effect of P. falciparum
[10,18]. In all cases, particular attention should be paid
to this secondary parasite. These secondary parasite
species should not be ignored particularly as control
interventions are planned and evaluated. Entomological
studies are also needed to identify anopheline species
which breed around the site and assess their vectorial
capacity for a better understanding of this increased
P. malariae prevalence.
In addition, the high proportion of gametocyte carriers
and gametocyte density observed among P. malariae-
infected children during the study period, suggests that
specific attention should be paid to this parasite. Indeed,
gametocytes are the currency of transmission from
human to mosquito for maintaining the malaria trans-
mission cycle. The presence and infectiousness of
gametocytes in circulation determines the success of
transmission from humans to mosquitoes. For now,
P. malariae gametocyte density and mosquito infection
are not well documented. Nevertheless it is well known
that lower Plasmodium density as well as submicro-
scopic density is infectious to mosquitoes [24,33]. Al-
though considered mild, P. malariae is known to cause
chronic infections which can last for years and might re-
occur decades after initial exposure when people have
long since left endemic regions [34]. Any level of infec-
tion with this species should be taken into account with
relevant treatment. Moreover, this study reports a
decrease of P. malariae asexual forms density and
gametocytes prevalence when P. falciparum is present.
With vaccine leading to the absence of P. falciparum,
the inhibitory effect on P. malariae may disappear.
Then, parasitaemia and gametocyte carriage of P.
malariae could increase and maintain severe malaria in-
fection. Within the context of vaccine being developed
against P. falciparum [35], this finding presents a great
epidemiological issue because the presence of non-
falciparum species will still be a serious health concern
to the communities at risk of infection.
The current data reveal that P. falciparum- and
P. malariae-specific gametocyte prevalence, gametocyte
and asexual form densities were higher in mono-
infection as compared to mixed infections. In summary,
the implications of these observations may have a pro-
found repercussion in the outcome of disease control. If
the simultaneous infection by other species inhibits
P. falciparum-gametocyte production [36] and if control
measures affect and reduce more effectively Plasmodium
species other than P. falciparum, this inhibitory effect
may disappear [28]. This finding is in agreement with
some previous studies on P. falciparum [28,36]. Indeed
in Thailand, Price et al. [36] reported that mixedinfections with P. falciparum and P. vivax are associated
with a reduction in the prevalence of P. falciparum
gametocytes. In the same way, Marques et al. [28] found
in Mozambique that P. falciparum gametocytes pre-
dominated in single infections. In contrast, it has been
reported from studies conducted in Columbia and Kenya
that P. malariae infection enhanced production of P. fal-
ciparum gametocytes [8,9]. These conflicting results
suggest that the relationship between mixed species
infections and gametocytaemia may be different under
different endemicities [9].
Then, variability in the interactions between species
under different transmission intensities, coupled with dif-
ferent sympatric species combinations may contribute to
observed differences in the epidemiology and clinical
presentations of malaria between endemic regions [10,37].
Finally, prevalences and densities recorded in the
current study may underestimate the real part of each
Plasmodium species. Much study report that parasite
prevalence under microscopy is 2.5-fold lower compared
to prevalence found with molecular method and this
fold difference was consistent across the different trans-
mission levels in individual studies [38-40] or meta-
analysis [41]. In light of these results, a longitudinal
parasitological survey using both microscopy and mo-
lecular tool are necessary to assess species-specific real
prevalence for a better understanding of species inter-
action. An entomological study is also need to evaluate
minor species gametocyte infectiousness and their con-
tribution to malaria transmission.Conclusion
Three species of malaria parasite are in circulation in
the study area, with a fluctuation of P. falciparum and
other species prevalence. These data revealed high gam-
etocyte prevalence in other Plasmodium species than
P. falciparum. The high proportion of gametocyte
carriers and gametocyte density across P. malariae-
infected children as well as the increase observed across
years, presents a great epidemiological issue in the con-
text of a vaccine being developed against P. falciparum.
The relevance of these data should be taken into ac-
count when general control strategies are planned.Competing interest
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